ClariVest Asset Management LLC increased its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 23.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 75,473 shares of the biopharmaceutical company’s stock after acquiring an additional 14,140 shares during the quarter. ClariVest Asset […]
NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3
TG Therapeutics Announces Schedule Of Data Presentations For BRIUMVI® (Ublituximab) In Multiple Sclerosis At The Americas Committee For Treatment And menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics (NASDAQ:TGTX – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Friday. TGTX has been the subject of a number of other research reports. JPMorgan Chase & Co. lifted their price target on shares of TG […]
E Fund Management Co. Ltd. raised its stake in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 170.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,010 shares of the biopharmaceutical company’s stock after acquiring an additional 27,744 shares during the […]